Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01468714 · ClinicalTrials.gov registry record · Phase 1
A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy Subjects
A Phase 1 study of Human Volunteers, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01468714 is a Phase 1 study of Human Volunteers that has completed, run by Pfizer. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01468714, a Phase 1 study of Human Volunteers, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the potential for a drug-drug interaction of PF-04937319 with ketoconazole, a potent inhibitor of the drug metabolizing enzyme CYP3A.
Conditions Studied
Interventions
- DRUG PF-04937319 / ketoconazole
Study Locations (1)
Connecticut
- Pfizer Investigational Site - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2011-10 |
| Est. Completion | 2011-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01468714
The ClinicalTrials.gov registry entry for NCT01468714 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Volunteers appearing as the primary indexed condition, and to 1 intervention - of which PF-04937319 / ketoconazole is the first listed.
NCT01468714 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT01468714 about?
NCT01468714 is a clinical study titled "A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy Subjects". This study will evaluate the potential for a drug-drug interaction of PF-04937319 with ketoconazole, a potent inhibitor of the drug metabolizing enzyme CYP3A.
What is the current status of trial NCT01468714?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2011-10. Estimated completion is 2011-10.
What conditions does trial NCT01468714 study?
This clinical trial studies the following conditions: Human Volunteers.
What interventions are being tested in trial NCT01468714?
The interventions under investigation include: PF-04937319 / ketoconazole (DRUG).
Who is sponsoring clinical trial NCT01468714?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01468714 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.